Cardiovascular Diseases and Nephrology Research
At Istituto Clinico Humanitas in Rozzano, clinical trials in cardiovascular disease and kidney disease focus on improving outcomes for people with atherosclerotic cardiovascular disease and chronic kidney disease. The studies are designed to evaluate whether new treatment approaches can better reduce major heart and vascular events.
- Research on atherosclerosis and its impact on long-term cardiovascular risk
- Trials in chronic kidney disease linked to cardiovascular outcomes
- Evaluation of new therapies aimed at preventing major cardiovascular events
These studies support the site’s work in nephrology and dialysis by exploring treatments that may protect both heart and kidney health.
Neoplasms and Breast Cancer Studies
The site also conducts oncology research in neoplasms, with a focus on metastatic breast cancer and estrogen receptor-positive, HER-2 negative advanced breast cancer. This trial activity is centered on testing whether a new treatment strategy can improve disease control compared with current options.
- Studies in advanced breast cancer with detectable ESR1 mutation
- Assessment of treatment effectiveness for metastatic breast cancer
- Research aimed at improving outcomes in hormone receptor-positive cancer
At Istituto Clinico Humanitas, this oncology work reflects a broader effort to refine therapies for difficult-to-treat breast malignancies.
